FIGURE 1. Relationship between red marrow absorbed dose estimates and development of thrombocytopenia after ¹⁸⁶Re-cMAb U36 radioimmunotherapy. Red marrow absorbed dose estimate was calculated using Bayesian analysis of limited blood sampling at 4 and 72 h after administration of ¹⁸⁶Re-cMAb U36.